When should a housing society in Mumbai start considering re...
From GST on JDAs to SEBI’s REIT reclassification and the S...
Stay ahead in the world of real estate with our daily podcas...
Stay ahead in the world of real estate with our daily podcas...
Sanofi Healthcare India, a subsidiary of the global healthcare giant Sanofi, has secured a lease for 270,000 sq ft of office space in Hitech City, Hyderabad. The lease, which began on January 1, covers six floors of the RMZ Spire-Tower 110. The agreement, registered earlier this month, includes a monthly rent of INR 75 per sq ft, amounting to INR 2.05 crore. The healthcare company has also paid a security deposit of INR 15.3 crore and committed to a five-year lock-in tenure with a provision for a 15% rent increase after three years.
Sanofi Healthcare India, a subsidiary of the global healthcare giant Sanofi, has made a significant move by leasing a sprawling 270,000 sq ft of office space in Hitech City, Hyderabad. The lease, which officially commenced on January 1, covers six floors of the RMZ Spire-Tower 110, a prominent commercial tower in one of the city's most dynamic business districts. Hitech City is a well-established hub for technology and business enterprises, making it an ideal location for companies aiming to tap into the region's growing infrastructure and talent pool.
Under the terms of the agreement, Sanofi will pay a monthly rent of INR 75 per sq ft, amounting to a total of INR 2.05 crore per month for the entire leased space. Additionally, the company has deposited INR 15.3 crore as a security amount, which is equivalent to 7.5 months of rent. The lease also includes a five-year lock-in period, ensuring that Sanofi's operations are firmly established at this location for an extended time. Furthermore, there is a provision in the lease agreement for a 15% rent escalation after three years, reflecting the anticipated growth and market conditions in the area.
Sanofi is well-known for its diverse portfolio of medicines, vaccines, and consumer health products, which are widely recognized for driving healthcare innovation globally. With this new office space, the company aims to strengthen its presence in the Indian market, which is becoming increasingly important in its global operations. Sanofi's focus on expanding its footprint in India reflects its long-term strategy of growth, innovation, and better service delivery in the region.
According to a source familiar with the deal, this strategic move underscores Sanofi's commitment to India as a key market. By securing office space in Hitech City, the company is not only investing in physical infrastructure but also tapping into the vibrant and diverse business ecosystem that Hyderabad offers. This location is known for its high-quality commercial spaces, easy access to top talent, and proximity to other multinational corporations, making it an attractive destination for global companies seeking to expand their operations in India.
In addition to its strategic importance, the lease agreement also highlights Sanofi's dedication to building a robust operational foundation in India. The company's move to expand its offices in Hyderabad is expected to create new opportunities for collaboration and innovation, positioning it for further growth in the coming years. This is also in line with broader trends in the Indian healthcare and pharmaceutical sectors, where foreign investments are increasing as the demand for medical and consumer health products continues to rise.
Sanofi's decision to lease 270,000 sq ft in Hitech City, Hyderabad, highlights its ongoing focus on expanding its footprint in India. The move is aligned with the company's growth strategy, leveraging the city's dynamic business environment to enhance its operations. The lease agreement, which involves a significant commitment, reflects the company's confidence in Hyderabad's potential as a hub for business and innovation.
5th Jun, 2025
25th May, 2023
11th May, 2023
27th Apr, 2023